Comment on Brekke, Dalen and Strøm: Should pharmaceutical costs be curbed?
Year of publication: |
2013
|
---|---|
Authors: | Tómasson Helgi |
Other Persons: | Brekke, Kurt R. (reviewed) ; Dalen, Dag Morten (reviewed) ; Strøm, Steinar (reviewed) |
Published in: |
Nordic economic policy review. - København, ISSN 1904-4526, ZDB-ID 2644490-2. - 2012, 2, p. 275-277
|
Subject: | Arzneimittel | Pharmaceuticals | Pharmaindustrie | Pharmaceutical industry |
-
Beyond the pill : the move towards value-addded services in the pharmaceutical industry
Wenzel, Meike, (2014)
-
Substitutability between drugs, innovation, and fiscal policy in the pharmaceutical industry
Mello-Sampayo, Felipa de, (2015)
-
Patents and R&D expenditure effects on equity returns in pharmaceutical industry
Feyzrakhmanova, Martina, (2016)
- More ...
-
Should pharmaceutical costs be curbed?
Brekke, Kurt R., (2013)
-
Diffusion of pharmaceuticals : cross-country evidence of anti-TNF drugs
Brekke, Kurt R., (2013)
-
Diffusion of pharmaceuticals : cross-country evidence of anti-TNF drugs
Brekke, Kurt R., (2014)
- More ...